About this trial
The goal of this observational study is to conduct a multicenter, prospective neonatal acute kidney injury (AKI) follow-up cohort to describe the clinical characteristics of chronic kidney disease (CKD) in AKI cases within 1 year of follow-up and screen for effective biomarkers that can early warn of CKD progression. Ultimately, a neonatal AKI adverse prognosis warning model based on multidimensional data will be established to provide new data and new models for CKD management.
Eligibility criteria
Qualifiers
Delivered in this hospital and subsequently admitted to the NICU during the study period;
Diagnosed with neonatal AKI according to the 2015 KDIGO neonatal AKI criteria;
Age <28 days.
Disqualifiers
Severe hydronephrosis diagnosed by prenatal renal ultrasound;
Patients with congenital urinary malformations, including solitary kidney, cystic dysplasia, multicystic dysplastic kidney, renal dysplasia, and obstructive uropathy;
Newborns who required congenital heart surgery within the first 7 days after birth;
Newborns whose mothers had a history of renal failure;
Trial design
Treatments tested in this trial
- Not listed